1.
N Z Med J
; 98(785): 711-2, 1985 Aug 28.
Article
in English
| MEDLINE
| ID: mdl-3863041
2.
N Z Med J
; 94(688): 52-4, 1981 Jul 22.
Article
in English
| MEDLINE
| ID: mdl-6944636
3.
N Z Med J
; 93(687): 1-2, 1981 Jul 08.
Article
in English
| MEDLINE
| ID: mdl-7022275
ABSTRACT
Thirty patients with essential hypertension (WHO Stage I or II) completed a double blind crossover trial in which they received metoprolol as monotherapy as either a slow release formulation of 200 mg once daily or a conventional formulation of 100 mg bd. Duration of treatment was six weeks on each preparation, given in randomised order. Mean values of resting blood pressure and heart rate, measured 22 to 24 hours after the daily dose of the SR formulation or 12-14 hours after the second dose of the conventional form were significantly lower than pretreatment levels. The two treatments were equally effective and equally well tolerated.
Subject(s)
Hypertension/drug therapy , Metoprolol/therapeutic use , Propanolamines/therapeutic use , Blood Pressure/drug effects , Clinical Trials as Topic , Delayed-Action Preparations , Double-Blind Method , Female , Heart Rate/drug effects , Humans , Hypertension/blood , Male , Metoprolol/administration & dosage , Metoprolol/blood , Middle Aged , Pulse/drug effects , Random Allocation
4.
Lebensversicher Med
; 33(3): 49-50, 1981 Mar 26.
Article
in English, German
| MEDLINE
| ID: mdl-6116124
5.
N Z Med J
; 79(512): 822-3, 1974 Apr 10.
Article
in English
| MEDLINE
| ID: mdl-4524823
Subject(s)
Asthma/epidemiology , Respiration , Asthma/diagnosis , Child , Female , Humans , Male , New Zealand , Respiratory Function Tests
6.
N Z Med J
; 67(431): 486-92, 1968 Apr.
Article
in English
| MEDLINE
| ID: mdl-5239793